178 studies found for:    panitumumab
Show Display Options
Rank Status Study
1 Terminated
Has Results
Panitumumab and Irinotecan for Malignant Gliomas
Condition: Malignant Glioma of Brain
Interventions: Drug: Irinotecan;   Drug: Panitumumab
2 Active, not recruiting Chemoradiation With Gemcitabine in Combination With Panitumumab for Patients With Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: Panitumumab
3 Active, not recruiting Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Panitumumab;   Drug: Carboplatin;   Drug: Gemcitabine
4 Completed Panitumumab Combination Study With AMG 102 or AMG 479 in Wild-type KRAS mCRC
Conditions: Colon Cancer;   Colorectal Cancer;   Gastrointestinal Cancer;   Metastatic Colorectal Cancer;   Rectal Cancer
Interventions: Drug: Panitumumab + AMG 102;   Drug: Panitumumab + AMG 479;   Drug: AMG 479;   Drug: AMG 102;   Drug: Panitumumab
5 Recruiting Maintenance Therapy With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction and Re-induction After Progress for 1st-line Treatment of Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Maintenance Chemotherapy;   Drug: Panitumumab (Within maintenance phase);   Drug: mFOLFOX6 (Within re-induction phase);   Drug: Panitumumab (Within re-induction phase)
6 Terminated Radio-chemotherapy With or Without Panitumumab (Vectibix®) in Irresectable Squamous Cell Carcinoma or Adenocarcinoma of the Oesophagus
Condition: Irresectable Squamous Cell or Adenocarcinoma of the Oesophagus
Interventions: Drug: CRT + Panitumumab;   Drug: Concurrent chemoradiation therapy without panitumumab
7 Recruiting Cabozantinib and Panitumumab to Treat KRAS Wild-Type Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Biological: Panitumumab;   Drug: Cabozantinib
8 Unknown  Panitumumab (Vectibix®) in Cutaneous Squamous Cell Carcinoma (SCC)
Condition: Carcinoma, Squamous Cell
Intervention: Drug: infusions of Panitumumab
9 Active, not recruiting Safety and Efficacy Study of FOLFOX4+Panitumumab vs.FOLFIRI+Panitumumab in Subjects WT KRAS Colorectal Cancer and Liver-only Metastases
Condition: Colorectal Cancer
Interventions: Drug: Panitumumab+FOLFOX-4;   Drug: Panitumumab+FOLFIRI
10 Completed
Has Results
Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patietnts With Advanced Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-Small Cell Lung Cancer
Interventions: Biological: Panitumumab;   Drug: Motesanib diphosphate;   Drug: Paclitaxel;   Drug: Carboplatin
11 Completed New Individualized Therapy Trial for Metastatic Colorectal Cancer
Conditions: Colorectal Neoplasm;   Colorectal Cancer
Interventions: Drug: Imatinib mesylate followed by a combination of imatinib mesylate & panitumumab;   Drug: Standard-of-care treatment with panitumumab
12 Terminated
Has Results
Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Panitumumab;   Procedure: Surgery;   Procedure: Radiation Therapy
13 Completed
Has Results
PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study
Condition: Colorectal Cancer
Interventions: Drug: Oxaliplatin Based Chemotherapy;   Drug: Panitumumab;   Drug: Irinotecan Based Chemotherapy;   Drug: Bevacizumab
14 Completed
Has Results
A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck
Condition: Squamous Cell Carcinoma of Head and Neck
Interventions: Drug: Panitumumab;   Drug: Cisplatin;   Drug: 5FU
15 Completed
Has Results
Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy
Conditions: Colorectal Cancer;   Metastatic Cancer
Intervention: Biological: Panitumumab
16 Completed
Has Results
Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: Irinotecan;   Biological: Panitumumab;   Drug: 5-Fluorouracil;   Drug: Leucovorin
17 Recruiting Panitumumab Pediatric Study
Condition: Solid Tumors
Intervention: Drug: Panitumumab Treatment
18 Recruiting Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type KRAS Who Have Resected Hepatic Metastases From Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: panitumumab;   Drug: Randomization to No Panitumumab
19 Completed Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors
Conditions: Tumors;   Oncology;   Solid Tumors
Interventions: Drug: panitumumab (ABX-EGF);   Drug: Panitumumab
20 Recruiting PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine)
Condition: Cholangiocarcinomas
Interventions: Drug: Cisplatin, Gemcitabine, Panitumumab;   Drug: Cisplatin, Gemcitabine

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years